|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2018||2019||2020||2021||2022||2023E||2024E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
The Cigna Group is a global health services company. Its portfolio of offerings solves diverse challenges across the healthcare system. It offers a differentiated set of pharmacy, medical, behavioral, dental, and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes a range of coordinated and point solution health services and capabilities, as well as those from partners across the health care system, in pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions, which are provided to health plans, employers, government organizations and health care providers. Evernorth Health Services also offers MDLIVE virtual care platform. Cigna Healthcare includes the United States Commercial, United States Government, and International Health operating segments, which provide medical and coordinated solutions to clients and customers.
- David Cordani CHM (55)
- Brian Evanko CFO (44)
- Charles Berg CEX (64)
- Eric Palmer CEX (44)
- Jason Sadler CEX (52)
- Michael Triplett CEX (59)
- Noelle Eder EVP (51)
- Kristen Lauria EVP (52)
- Nicole Jones EVP (50)
- John Murabito EVP (62)
- Everett Neville EVP (56)
- Paul Sanford EVP
- Eric Wiseman LED (65)
- William DeLaney IND (65)
- Eric Foss IND (62)
- Elder Granger IND (68)
- Neesha Hathi IND
- George Kurian IND (54)
- Kathleen Mazzarella IND (61)
- Mark Mcclellan IND (57)
- John Partridge IND (71)
- Kimberly Ross IND (56)
- Donna Zarcone IND (63)
Latest News for CI
Upcoming Events for CI
Dividend For C1IC34.SA - 1.5392 BRL
Dividend For CI.N - 1.2300 USD
Q4 2023 Cigna Group Earnings Call
Q4 2023 Cigna Group Earnings Release
The Cigna Group Annual Shareholders Meeting
Q1 2024 Cigna Group Earnings Call
Q1 2024 Cigna Group Earnings Release
As of Today at 18:05 UTC, shares in Cigna are trading at $269.02. This share price information is delayed by 15 minutes.
Shares in Cigna last closed at $269.02 and the price had moved by -16.83% over the past 365 days. In terms of relative price strength the Cigna share price has underperformed the S&P500 Index by -26.29% over the past year.
The overall consensus recommendation for Cigna is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Cigna dividend yield is 1.79% based on the trailing twelve month period.
Last year, Cigna paid a total dividend of $4.81, and it currently has a trailing dividend yield of 1.79%.Looking ahead, shares in Cigna are due to go ex-dividend on 2023-12-05 and the next dividend pay date is 2023-12-21.
Cigna are due to go ex-dividend on 2023-12-05 and the next dividend pay date is 2023-12-21. The historic dividend yield on Cigna shares is currently 1.79%.
To buy shares in Cigna you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $269.02, shares in Cigna had a market capitalisation of $78.72bn.
Here are the trading details for Cigna:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: CI
Based on an overall assessment of its quality, value and momentum Cigna is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Cigna is $347.81. That is 29.29% above the last closing price of $269.02.
Analysts covering Cigna currently have a consensus Earnings Per Share (EPS) forecast of $24.84 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cigna. Over the past six months, its share price has underperformed the S&P500 Index by -2.64%.
As of the last closing price of $269.02, shares in Cigna were trading -3.35% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cigna PE ratio based on its reported earnings over the past 12 months is 9.62. The shares last closed at $269.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Cigna's management team is headed by:
- David Cordani - CHM
- Brian Evanko - CFO
- Charles Berg - CEX
- Eric Palmer - CEX
- Jason Sadler - CEX
- Michael Triplett - CEX
- Noelle Eder - EVP
- Kristen Lauria - EVP
- Nicole Jones - EVP
- John Murabito - EVP
- Everett Neville - EVP
- Paul Sanford - EVP
- Eric Wiseman - LED
- William DeLaney - IND
- Eric Foss - IND
- Elder Granger - IND
- Neesha Hathi - IND
- George Kurian - IND
- Kathleen Mazzarella - IND
- Mark Mcclellan - IND
- John Partridge - IND
- Kimberly Ross - IND
- Donna Zarcone - IND